$OGN 90 DAYS STOCK PRICE FORECAST

Stock Price

About the Company

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon sells to international markets.

Exchange

NEW YORK STOCK EXCHANGE INC.

$8B

Total Revenue

None

Employees

$9B

Market Capitalization

4.95

Price/Earning ratio

Industry Peers

Name Ticker Market Capitalization (USD M) Revenue (USD M) Price/Book Price/Earning Net Margin (%)
Conversion Labs Inc CVLB 108548 35213 3.74 42.66 7.33
Royalty Pharma plc RPRX 19327 2239 2.87 15.52 43.40
Organon & Co. OGN 8644 7891 -4.46 4.95 22.06
Arvinas Inc ARVN 4342 21 8.14 -26.29 -782.93
Tilray Inc TLRY 3286 513 1.23 -9.74 -71.61
ATAI Life Sciences N.V. ATAI 2545 20 5.35 -11.65 -932.88
Cronos Group Inc CRON 2114 57 1.33 -14.64 -258.59
Usana Health Sciences Inc USNA 1837 1254 4.18 13.23 11.09
Phathom Pharmaceuticals Inc PHAT 1178 7.99 -7.35 None
Fulcrum Therapeutics Inc FULC 925 15 11.21 -12.53 -481.07
Intersect ENT Inc XENT 899 103 21.80 -13.10 -66.55
Phibro Animal Health Corp. PAHC 888 833 3.68 16.16 6.53
Edgewise Therapeutics Inc EWTX 848 2.87 -31.45 None
Pliant Therapeutics Inc PLRX 657 13 2.69 -7.66 -613.56
Cyteir Therapeutics Inc CYT 637 3.42 -22.04 None
Urovant Sciences Ltd UROV 503 -3.65 -3.08 None
Ikena Oncology Inc IKNA 467 10 2.52 -8.53 -551.28
Chromadex Corp CDXC 433 62 10.92 -18.30 -37.51
Rain Therapeutics Inc RAIN 404 413 2.50 -13.27 123.20
Provention Bio Inc PRVB 400 2.68 -3.12 None
Evolus Inc EOLS 321 77 4.24 -2.15 -171.53
Verrica Pharmaceuticals Inc VRCA 316 12 6.41 -8.69 -301.45
Terns Pharmaceuticals Inc TERN 263 1.46 -7.62 None
Adicet Bio Inc ACET 230 9 1.00 -4.09 -603.06
Milestone Pharmaceuticals Inc MIST 222 15 1.25 -7.50 -215.93
Kaleido Biosciences Inc KLDO 222 1 4.94 -2.49 None
LifeMD Inc LFMD 201 64 -28.62 -1.44 -133.55
Kala Pharmaceuticals Inc KALA 187 11 2.42 -1.48 None
Osmotica Pharmaceuticals Plc OSMT 181 190 2.64 -1.95 -47.85
Citius Pharmaceuticals Inc CTXR 177 2.21 -7.70 None
scPharmaceuticals Inc SCPH 162 119 2.38 -5.36 -27.05
Aquestive Therapeutics Inc AQST 146 42 -3.02 -2.27 -152.73
Eton Pharmaceuticals Inc ETON 123 15 6.11 -10.06 -74.52
Odonate Therapeutics Inc ODT 117 1.47 -1.00 None
Eyenovia Inc EYEN 113 6 12.86 -5.77 -324.94
Aerpio Pharmaceuticals Inc ARPO 99 15 2.98 -5.24 -28.77
Opiant Pharmaceuticals Inc OPNT 90 37 2.71 -86.08 -3.06
Natural Alternatives Internati NAII 89 169 1.26 10.07 5.68
VYNE Therapeutics Inc VYNE 72 16 1.08 3.27 -554.66
India Globalization Capital In IGC 67 0 2.39 -7.65 -981.18
Mannatech Inc MTEX 66 158 2.63 10.35 4.22
Acasti Pharma Inc ACST 42 0 1.81 -2.11 -611.47
Shineco Inc TYHT 36 14 1.85 -1.78 -159.60
Assertio Holdings Inc ASRT 33 117 0.45 -0.58 -38.05
Reviva Pharmaceuticals Holding RVPH 30 1.64 -4.74 None
Baudax Bio Inc BXRX 28 1 -11.98 0.84 None
Nabriva Therapeutics Plc NBRV 28 12 0.83 -0.47 -452.55
Bio-Path Holdings Inc BPTH 28 0 1.29 -2.68 18.96
Timber Pharmaceuticals Inc TMBR 26 0 11.39 0.88 -527.55
Trevi Therapeutics Inc TRVI 26 1.67 -0.74 None
Lexaria Bioscience Corp LEXX 25 1 3.49 -6.45 -445.15
Hoth Therapeutics Inc HOTH 22 1.85 -2.29 None
Cyanotech Corp. CYAN 17 34 0.99 13.57 3.83
Sonoma Pharmaceuticals Inc. SNOA 11 17 3.13 -2.04 -31.96

Blackrock Funds Buys Organon

1d ago, source: YAHOO!Finance

Investment company Blackrock Funds (Current Portfolio) buys Organon during the 3-months ended 2021Q2, according to the most recent filings of the investment company, Blackrock Funds.

Organon makes women’s health a priority

28d ago, source: pharmaphorum.com

Organon has touched ground in a few areas, including therapeutics and disease areas, but is looking to expand its portfolio based on women’s needs both throughout their lifetime and in areas ...

Organon To Present at Citi’s 16th Annual BioPharma Virtual Conference

16d ago, source: Yahoo Finance

JERSEY CITY, N.J., September 01, 2021--(BUSINESS WIRE)--Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to ...

Organon To Present at Morgan Stanley’s 19th Annual Global Healthcare Virtual Conference

16d ago, source: Business Wire

JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a ...

What 6 Analyst Ratings Have To Say About Organon

16d ago, source: Benzinga.com

These 6 analysts have an average price target of $36.5 versus the current price of Organon at 35.155, implying upside. Below is a summary of how these 6 analysts rated Organon over the past 3 months.

Essence and Entailment in the Organon

3d ago, source: Cambridge University Press

Aristotle's Modal Logic, first published in 1995, presents an interpretation of Aristotle's logic by arguing that a proper understanding of the system depends on an appreciation of its connection to ...

Cal Poly HotHouse Company Started as a Senior Project. It Just Sold for $240 Million

3d ago, source: Noozhawk

The company, originally called InPress Technologies and now Alydia Health, sold this month to the Merck-spinoff company Organon for $240 million. Cal Poly students and a team of San Luis Obispo ...

Merck & Co., Inc. (MRK) CEO Robert Davis Presents at Morgan Stanley 19th Annual Global Healthcare Conference (Transcript)

4d ago, source: Seeking Alpha

We feel very good about where we are. We've completed the Organon spin-off. We made it through that with really no disruptions or surprises. And in fact, both Organon and Merck are operating at or ...

MVP: Gibson Dunn's Pamela Lawrence Endreny

9d ago, source: Law360

The team later advised Merck on the tax issues concerning Euro-and dollar-denominated secured and unsecured debt financing in connection with the spinoff of Organon, a global health care company.

Organon To Present at Citi’s 16th Annual BioPharma Virtual Conference

16d ago, source: Business Wire

JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fire ...

Essence and Entailment in the Organon

3d ago, source: Cambridge University Press

Looking for an examination copy? This title is not currently available for examination. However, if you are interested in the title for your course we can consider offering an examination copy. To ...

Your Portfolio